Lilly Mark

Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice

Ying Gao, D. Vasilyev, Maria B. Goncalves et al. · Journal of Neuroscience · 2010 · 477 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Kenneth J. Valenzano, Laykea Tafesse, Gary Lee et al. · Neuropharmacology · 2005 · 285 citations

Medicine, Pharmacokinetics, Pharmacology +13

N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain

James D. Pomonis, James Harrison, Lilly Mark et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 261 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Monoacylglycerol Lipase Activity Is a Critical Modulator of the Tone and Integrity of the Endocannabinoid System

Pranab K. Chanda, Ying Gao, Lilly Mark et al. · Molecular Pharmacology · 2010 · 229 citations

Medicine, Neuroscience, Pharmacology +14

Pharmacological characterisation of a rat model of incisional pain

Garth T. Whiteside, James Harrison, Jamie Boulet et al. · British Journal of Pharmacology · 2004 · 155 citations · Full text

Medicine, Pharmacology, Surgery +17